Related references
Note: Only part of the references are listed.Sex and gender differences in the use of oral anticoagulants for non-valvular atrial fibrillation: A population-based cohort study in primary health care in catalonia
Maria Giner-Soriano et al.
FRONTIERS IN PHARMACOLOGY (2023)
Data Resource Profile: The Information System for Research in Primary Care (SIDIAP)
Martina Recalde et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2022)
Head-to-head efficacy and safety of rivaroxaban, apixaban, and dabigatran in an observational nationwide targeted trial
Yeela Talmor-Barkan et al.
European Heart Journal-Cardiovascular Pharmacotherapy (2022)
Automatic Estimation of the Most Likely Drug Combination in Electronic Health Records Using the Smooth Algorithm: Development and Validation Study
Dan Ouchi et al.
JMIR MEDICAL INFORMATICS (2022)
Effectiveness and Safety of Direct Oral Anticoagulants in Relation to Temporal Changes in Their Use
So-Ryoung Lee et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2020)
Effectiveness and safety of rivaroxaban versus warfarin in obese nonvalvular atrial fibrillation patients: analysis of electronic health record data
Olivia S. Costa et al.
CURRENT MEDICAL RESEARCH AND OPINION (2020)
Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation The NAXOS Study
Eric Van Ganse et al.
STROKE (2020)
Graphical Depiction of Longitudinal Study Designs in Health Care Databases
Sebastian Schneeweiss et al.
ANNALS OF INTERNAL MEDICINE (2019)
Stroke and bleeding with non-vitamin K antagonist oral anticoagulant or warfarin treatment in patients with non-valvular atrial fibrillation: a population-based cohort study
Tomas Forslund et al.
EUROPACE (2018)
Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study
L. Staerk et al.
JOURNAL OF INTERNAL MEDICINE (2018)
Impact of medication adherence on risk of ischemic stroke, major bleeding and deep vein thrombosis in atrial fibrillation patients using novel oral anticoagulants
Chinmay G. Deshpande et al.
CURRENT MEDICAL RESEARCH AND OPINION (2018)
Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care
Yana Vinogradova et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based study from UK primary care
Shankar Kumar et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care
Yana Vinogradova et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based study from UK primary care
Shankar Kumar et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study
Neena S. Abraham et al.
GASTROENTEROLOGY (2017)
Comparative effectiveness of dabigatran and rivaroxaban versus warfarin for the treatment of non-valvular atrial fibrillation
Lindsay G. S. Bengtson et al.
JOURNAL OF CARDIOLOGY (2017)
The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation
Vaibhav Keskar et al.
KIDNEY INTERNATIONAL (2017)
Non-vitamin K oral anticoagulants are non-inferior for stroke prevention but cause fewer major bleedings than well-managed warfarin: A retrospective register study
Vilhelm Sjogren et al.
PLOS ONE (2017)
Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in real-world clinical practice
Xiaoyan Li et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
Peter Bronnum Nielsen et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
Peter Bronnum Nielsen et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Newly Diagnosed Atrial Fibrillation
Inmaculada Hernandez et al.
AMERICAN JOURNAL OF CARDIOLOGY (2017)
A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants
Sigrun Halvorsen et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2017)
Comparison of effectiveness and safety of treatment with apixaban vs. other oral anticoagulants among elderly nonvalvular atrial fibrillation patients
Steven Deitelzweig et al.
CURRENT MEDICAL RESEARCH AND OPINION (2017)
Direct Oral Anticoagulants for the Management of Thromboembolic Disorders: The Importance of Adherence and Persistence in Achieving Beneficial Outcomes
Alpesh Amin et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2016)
Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
Xiaoxi Yao et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation
Xiaoxi Yao et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
Robert P. Giugliano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Measurement of adherence in pharmacy administrative databases: A proposal for standard definitions and preferred measures
Lisa M. Hess et al.
ANNALS OF PHARMACOTHERAPY (2006)
Share Paper
